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Using Cardiopulmonary Exercise Testing to
Evaluate Fatigue and Post-Exertional
Malaise in ME/CFS
The absence of reliable diagnostic laboratory
tests or biomarkers presents significant problems
for persons with Myalgic
Encephalomyelitis/Chronic Fatigue Syndrome
(ME/CFS), treating physicians, and the ME/CFS
research community alike. Typically ME/CFS
diagnoses rely on self-report measures where
patients describe the extent and duration of
their fatigue and attendant symptoms either
verbally or on a questionnaire.
An alternative to the current binary approach
(i.e., fatigue or no fatigue) or use of paper and
pencil inventories for evaluation of symptoms in
ME/CFS is to employ direct, objective multisystem, measures of physical function that may
also provide insights to the underlying
pathophysiology of fatigue in ME/CFS. One such
methodology is cardiopulmonary exercise
testing (CPET). With a long history of use by
exercise physiologists in research settings, this
non-invasive, integrative assessment approach
is now increasingly endorsed for the clinical
evaluation of undiagnosed exercise intolerance
and for the objective determination of
functional capacity and impairment.[1]
An early definition conceptualizes fatigue as
reduced efficiency after doing work.[2] CPET is
uniquely able to quantify this reduction in
efficiency with measures of both workload and
the metabolic cost of that work. Additionally,
other available cardiovascular, pulmonary and
symptom data further enhance the value of
CPET for diagnostic, clinical and research
purposes.
As a corollary to extreme fatigue, postexertional malaise (PEM) or exacerbation of
symptoms following physical exertion, is
considered one of the most common and
recognizable aspects of ME/CFS. For the
objective assessment of PEM, CPET has the
advantage of serving as both an indicator of
clinical status and a quantifiable model of
physical exertion.
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Physical exertion requires that the
cardiovascular system supply oxygen (O2) to
active muscles and the pulmonary system
remove carbon dioxide (CO2) from the blood.
Taxing these systems has the capacity to reveal
abnormalities that may not be apparent at rest
and thus elucidate the mechanisms underlying
exercise intolerance in ME/CFS. Procedures for
CPET are widely available [1] as are results
profiles for a variety of disabling conditions. [3]
These data can facilitate differential diagnosis
to rule out conditions that could otherwise
explain patient symptoms.
CPET is generally performed using a motorized
treadmill or stationary cycle ergometer. For
reasons of safety, the cycle is preferable when
testing ME/CFS patients. Possible orthostatic
intolerance and the extreme exhaustion
patients usually experience post-testing can
make using a treadmill particularly hazardous.
Individualized ramp protocols, which involve

The principles underlying CPET are simple.
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only modest increases in work rate per stage
should be used and tailored to yield a fatiguelimited exercise duration of 8 to 12 minutes.
Longer durations may result in patients
terminating exercise because of specific muscle
fatigue or orthopedic factors rather than
cardiopulmonary end points. An important
consideration for ME/CFS is to begin the test at
a very low workload. Starting at too high a level
will make for a very short test with results that
are difficult to interpret. Test durations of less
than 6 minutes may not show a linear
relationship between oxygen consumption and
work-rate. [1]
Some of the key measures available from CPET
include: maximal aerobic capacity (Peak VO2
or VO2 max ); ventilatory or anaerobic threshold
(VT); and peak respiratory exchange ratio (RER).
In addition to these gas exchange variables,
workload at any given point and, with the
integration of electrocardiography, key
indicators of cardiovascular dynamics can also
be measured.
Often synonymous with functional capacity or
exercise tolerance, Peak VO2 defines the
physiological limits of an individual. However it is
important to note that when such terms are
used to describe performance on activities like
timed-walk tests, or the commercial functional
capacity assessments often used to evaluate
disability, these are only estimates of aerobic
capacity which tend to overpredict VO2 .[1]
CPET is required for precise measurement of
functional capacity.
Most activities of daily living (ADL) are
performed at levels below peak. VT is an
important index of submaximal exercise
capacity. It denotes the point at which energy
production transitions from primarily aerobic to
increasingly anaerobic glycolosis and is a
crucial measure in CPET as it represents the
onset of fatigue. Due to a lack of oxygen in the
working muscle cells, work intensity cannot be
maintained resulting in the reduction or
cessation of activity. It may also be central to
Invest in ME (Charity Nr. 1114035)

understanding the activity limitations in ME/CFS.
If VT occurs at very low levels of oxygen
consumption and/or at very low workloads,
then even normal ADL may exceed the VT
threshold. It is possible therefore that in ME/CFS
the increased stress of requiring a greater
anaerobic energy contribution even for normal
ADL precipitates the symptom exacerbation
seen in PEM. CPET provides the only way to noninvasively assess this significant transition point in
energy metabolism.
Assessment of subject effort might be
considered essential to interpreting any
measure of physiological function. Exclusive to
expired gas analysis, RER is defined as the ratio
between inspired O2 and expired CO2. As
exercise intensity increases the volume of CO2
begins to exceed that of O2. A ratio of CO2 to
O2 greater than 1.10 is considered an indicator
of excellent effort during an exercise test .[1] As
an accurate and reliable indication of subject
effort, RER substitutes for age-predicted
maximal heart-rate values in this respect.
Variability of 10-15 beats per minute can be
expected within an age group which
complicates interpretation of results where
percentage of predicted maximal heart rate is
the exercise endpoint.[4] There are also
difficulties posed by use of pharmacological
agents [1] and the cardiovascular abnormalities
seen in ME/CFS.[5] Problems of response bias in
self-report indictors of effort are also averted.
Because RER permits accurate comparison of
subject effort across serial exercise tests, it
should be of prime consideration for any clinical
intervention trial with functional endpoints.[1]
CPET data including RER also allow for the more
reliable interpretation of results when an
exercise challenge is used to elicit symptoms as
part of ME/CFS research studies. As a
quantifiable measure of both physiological
stress and effort, CPET enables direct
comparison between patients and controls on
these critical measures. This may be particularly
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relevant to research looking at immune function
where individual fitness levels and exercise
intensity can profoundly affect the immune
response.[6]
The availability of RER also gives CPET the
capacity to objectively document PEM in
ME/CFS patients. The reproducibility of both
metabolic and work intensity measures obtained
through CPET is well documented.[1] But
research using CPET to examine functional
capacity in CFS has found that a single test may
be insufficient to identify abnormalities in work
performance among CFS patients.[7, 8] By
employing a dual test paradigm (i.e., 2 exercise
tests, each separated by 24 hours) it is possible to
compare data across tests. A significant change
in exercise capacity during follow-up testing with
similar peak RER values, it could be argued, is
clear evidence of PEM. It should also be noted
that RER is a critical arbiter when dealing with
accusations of malingering or lack of effort!
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From over 2,000 pages of information
obtained under the Freedom of Information
Act, much is already known about the design
and progress of the PACE Trial, including the
fact that its entry criteria were intentionally
broad (“We chose these broad criteria in
order to enhance generalisability and
recruitment”; Trial Identifier 3.6).
Despite the use of such broad entry criteria,
there were serious recruitment difficulties, so
the entry criteria were broadened even
further when on 14th July 2006 Peter White
sought approval from the West Midlands
MREC to write to GPs imploring them to send
anyone with “chronic fatigue (or synonym)”
for entry into the PACE Trial, thereby opening
the trial to anyone who was merely
chronically tired.
from Magical Medicine: How to Make a
Disease Disappear http://tinyurl.com/38yuj83
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